Multi-mode focused ultrasound system based on feeding blood vessel occlusion

By using a multi-mode focused ultrasound system that blocks the feeding vessels, combined with thermal effects and tissue destruction modes, the problems of insufficient ablation range and incomplete treatment of feeding vessels in existing tumor treatment technologies have been solved, achieving a more efficient and safer tumor ablation effect.

CN121243664APending Publication Date: 2026-01-02ZHONGHUI MEDICAL TECH (SHANGHAI) CO LTD
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202511822041.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-12-05
Publication Date
2026-01-02

AI Technical Summary

Technical Problem

Current focused ultrasound tumor treatment methods have risks of insufficient ablation range, residual tumor at the edges, or thermal damage to surrounding healthy tissue when treating large or poorly defined tumors. They also fail to effectively treat the tumor's feeding vessels, which may lead to fibroid regeneration or enlargement and pose a risk of bleeding.

Method used

A multi-mode focused ultrasound system based on vascular occlusion is used, combining thermal effect mode and tissue destruction mode. The target tissue data is acquired through the detection imaging unit, and the control unit formulates the irradiation plan to achieve vascular occlusion and tissue destruction of the target tissue, including the coordinated implementation of thermal ablation and tissue destruction modes.

Benefits of technology

It effectively blocks the blood supply to the target tissue, ensures complete tumor ablation, reduces marginal residue and damage to healthy tissue, improves treatment efficacy, reduces the risk of fibroid recurrence, and reduces intraoperative bleeding.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121243664A_ABST
    Figure CN121243664A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of medical equipment, and provides a multi-mode focused ultrasound system based on supply blood vessel occlusion, comprising: a focused ultrasound unit comprising an ultrasonic treatment head and an ultrasonic driving circuit connected with each other; the detection imaging unit is used for detecting the target tissue to obtain target tissue data containing blood vessel information; the control unit is used for determining an irradiation plan based on the target tissue data, and executing the irradiation plan through the focused ultrasound unit, including: performing focused ultrasound irradiation on a supply blood vessel of a target tissue in a heat effect mode to form thermal ablation; and irradiating the target tissue that blocks blood supply in the histotripsy mode in the event that the histotripsy mode is adapted to the target tissue. The system disclosed by the invention can be used for realizing multi-mode cooperative implementation of supply blood vessel treatment, heat effect and tissue destruction of target tissues, and effectively solves the problems of tissue blood vessel residue, single treatment mode and the like in focused ultrasonic treatment in related technologies.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This disclosure relates to the field of medical equipment technology, and in particular to a multimodal focused ultrasound system based on the occlusion of supplying blood vessels. Background Technology

[0002] Focused ultrasound (FUS) has been increasingly widely used in clinical tumor treatment due to its non-invasive nature. Its principle is based on the ability of ultrasound waves to penetrate human tissue without damage and focus within the body, producing thermal effects (the primary effect), cavitation effects, and mechanical effects. The temperature at the focal point rises, causing coagulative necrosis of the tissue at that point without damaging normal structures outside the focal point.

[0003] Existing tumor thermal ablation techniques (such as radiofrequency, microwave, and laser) primarily induce tissue coagulation and necrosis through thermal effects. However, when treating larger tumors or tumors with indistinct borders, there are risks of insufficient ablation area, residual tissue at the edges, or thermal damage to surrounding healthy tissue. Cavitation techniques (such as high-intensity focused ultrasound cavitation and laser-induced cavitation) directly destroy cell structures through mechanical effects (shock waves, microjets), and are particularly adept at liquefying internal tissues. However, they are sensitive to tissue type and density, and using them alone may not ensure complete inactivation at the edges and may result in insufficient induction of immunogenic cell death. Currently, there is a lack of effective treatment regimens that integrate the two physical effects, leverage their respective advantages, and synergistically enhance the immune response.

[0004] Furthermore, current thermal ablation and tissue destruction techniques primarily focus on destroying the tumor as a whole, neglecting the treatment of its feeding vessels. This can lead to the retention of these vessels supplying the fibroid, allowing internal tissue to continue growing and potentially causing the fibroid to regenerate or enlarge, resulting in treatment failure or recurrence. Moreover, in cases like highly vascularized tumors, failure to address them can lead to significant bleeding during surgery, posing a substantial risk.

[0005] It is evident that the current treatment methods using focused ultrasound to ablate tumors have many shortcomings. Finding a more effective focused ultrasound approach for tumor treatment that overcomes these deficiencies has become a pressing technical challenge for the industry. Summary of the Invention

[0006] In view of the shortcomings of the prior art described above, the purpose of this disclosure is to provide a multi-mode focused ultrasound system based on the occlusion of the feeding vessel to solve the problems in the related art.

[0007] The first aspect of this disclosure provides a multi-mode focused ultrasound system based on vascular occlusion, comprising: a focused ultrasound unit including a connected ultrasound treatment head and an ultrasound drive circuit; the ultrasound drive circuit allows controlled driving of the ultrasound treatment head to output focused ultrasound in multiple treatment modes; the multiple treatment modes include a thermal effect mode and a tissue ablation mode; a detection imaging unit for detecting target tissue to obtain target tissue data containing vascular information; and a control unit connected to the ultrasound drive circuit and the detection imaging unit for determining an irradiation plan based on the target tissue data and executing the irradiation plan through the focused ultrasound unit, including: irradiating the vascular supply of the target tissue with focused ultrasound in the thermal effect mode to form thermal ablation, thereby blocking the blood supply of the target tissue; and, when the tissue ablation mode is adapted to the target tissue, irradiating the target tissue in the tissue ablation mode to form destruction.

[0008] In an embodiment of the first aspect, the method of performing focused ultrasound irradiation on the blood vessels supplying the target tissue in thermal effect mode to form thermal ablation includes at least one of the following: irradiating each connection point between the target tissue and the external blood vessels to block the external blood supply to the target tissue; irradiating the blood vessels supplying the target tissue to block blood flow; and irradiating at least one external point on the external blood vessels that is further away from the target tissue from the connection point with the target tissue to form an occlusion point.

[0009] In an embodiment of the first aspect, the method of performing focused ultrasound irradiation on the blood vessels supplying the target tissue in thermal effect mode to form thermal ablation includes at least one of the following: irradiating the various connection points between the target tissue and the external blood vessels at the inside / outside and surface of the target tissue to block the external blood supply to the target tissue; irradiating the blood vessels supplying the target tissue to block blood flow; and irradiating at least one external point on the external blood vessels that is further away from the target tissue from the connection points with the target tissue to form an occlusion point.

[0010] In an embodiment of the first aspect, the irradiation plan includes: irradiating the various connection points between the target tissue and the external blood supply vessels in a thermal effect mode to block the external blood supply to the target tissue; and, if the target tissue is adapted to a tissue destruction mode, performing fragmented focused ultrasound irradiation on the target tissue before / after the blood supply is blocked in a tissue destruction mode.

[0011] The irradiation plan of the organization further includes: focusing ultrasound irradiation of the peripheral region of the target tissue in either thermal effect mode or tissue destruction mode; wherein, if focusing ultrasound irradiation is performed in thermal effect mode, the peripheral region and each of the connection points are irradiated together with focusing ultrasound.

[0012] In an embodiment of the first aspect, prior to irradiating each connection point between the target tissue and the external supply vessel in thermal effect mode, the irradiation plan further includes: performing focused ultrasound irradiation on at least one external point on the external supply vessel that is further away from the target tissue from the connection point with the target tissue in thermal effect mode to form a blocking point.

[0013] In an embodiment of the first aspect, the target tissue is a hypervascular tissue; the irradiation plan includes: focusing ultrasound irradiation of the blood vessels supplying the hypervascular tissue in a thermal effect mode to form thermal ablation.

[0014] In an embodiment of the first aspect, the control unit is further configured to continue performing focused irradiation in at least one round of thermal effect mode and / or tissue destruction mode in response to the presence of stubborn / residual portions of the irradiated target tissue.

[0015] In an embodiment of the first aspect, the irradiation plan includes: performing focused ultrasound irradiation on the bifurcation point of the feeding vessel in a thermal effect mode to form thermal ablation; or, performing focused ultrasound irradiation on a feeding vessel selected from multiple downstream branch vessels based on a bifurcation point in a thermal effect mode to form thermal ablation.

[0016] In an embodiment of the first aspect, determining the irradiation plan based on the target tissue data further includes: acquiring tissue characteristic data of the target tissue, the tissue characteristic data including at least tissue stiffness; determining a suitable treatment mode in a mode library based on the tissue characteristic data to formulate an irradiation plan; wherein the suitable treatment mode changes from a tissue destruction mode to a thermal effect mode or from a thermal effect mode to a tissue destruction mode as the tissue characteristic data, or the tissue characteristic data and other imaging data used in conjunction, change.

[0017] In an embodiment of the first aspect, determining the irradiation plan based on the target tissue data includes: determining zonal irradiation requirements based on the size and / or type of the target tissue; determining a peripheral region and an intermediate region of the target tissue in response to the zonal irradiation requirements; and determining one of a tissue destruction mode and a thermal effect mode for achieving thermal ablation for the peripheral region and the intermediate region, respectively.

[0018] In an embodiment of the first aspect, determining the irradiation plan based on the tissue characteristic data further includes: determining an enhanced irradiation requirement based on the tissue characteristic data; and, in response to the enhanced irradiation requirement, sequentially applying one of a thermal effect mode and a tissue destruction mode to the target tissue to enhance the tissue destruction and / or thermal ablation effect.

[0019] As described above, this disclosure relates to the field of medical equipment technology, providing a multi-mode focused ultrasound system based on vascular occlusion, comprising: a focused ultrasound unit including a connected ultrasound treatment head and an ultrasound drive circuit; the ultrasound drive circuit allows controlled driving of the ultrasound treatment head to output focused ultrasound in multiple treatment modes; a detection imaging unit for detecting target tissue to obtain target tissue data containing vascular information; and a control unit for determining an irradiation plan based on the target tissue data and executing the irradiation plan through the focused ultrasound unit, including: irradiating the vascular supply of the target tissue with focused ultrasound in a thermal effect mode to form thermal ablation; and, when a tissue destruction mode is adapted to the target tissue, irradiating the target tissue whose blood supply is blocked in a tissue destruction mode. The system in this disclosure can be used to simultaneously realize the coordinated implementation of multiple modes of target tissue vascular treatment, thermal effect, and tissue destruction, effectively solving the problems of residual tissue vessels and single treatment mode in focused ultrasound treatment in related technologies. Attached Figure Description

[0020] Figure 1 A schematic diagram of a multi-mode focused ultrasound system based on vascular occlusion is shown in one embodiment of this disclosure.

[0021] Figure 2 A schematic diagram illustrating the connection point between the target tissue and the external supply blood vessel in one embodiment of this disclosure is shown.

[0022] Figure 3 A schematic diagram showing the connection point and external point between the target tissue and the external supply blood vessel in one embodiment of this disclosure is provided.

[0023] Figure 4 A schematic diagram illustrating the blocking of blood vessels supplying the target tissue in one embodiment of this disclosure is shown.

[0024] Figure 5 This diagram illustrates a multi-mode focused ultrasound system blocking blood supply to the target tissue in one application example of this disclosure.

[0025] Figure 6 Showing Figure 5 A schematic diagram illustrating tissue destruction in target tissue after blood supply is blocked.

[0026] Figure 7 Showing Figure 6 A schematic diagram of focused irradiation of the peripheral region of the target tissue after intermediate treatment.

[0027] Figure 8 This diagram illustrates the destruction of the central region of a target tissue by a multimodal focused ultrasound system in yet another application example of this disclosure.

[0028] Figure 9 Showing Figure 8A schematic diagram of thermal ablation of the peripheral region of the target tissue after treatment to simultaneously block blood supply and scan the edges.

[0029] Figure 10 This diagram illustrates a multi-mode focused ultrasound system blocking blood supply to the target tissue in another application example of the present disclosure.

[0030] Figure 11 Showing Figure 10 A schematic diagram illustrating tissue destruction in target tissue after blood supply is blocked.

[0031] Figure 12 This illustration shows a schematic diagram of focused ultrasound irradiation of a bifurcated feeding vessel according to an embodiment of the present disclosure.

[0032] Figure 13 This illustration shows a schematic diagram of focused ultrasound irradiation of a bifurcated feeding vessel in yet another embodiment of the present disclosure.

[0033] Figure 14 A flowchart illustrating a method for determining a treatment modality for a target tissue based on tissue characteristics is shown in one embodiment of this disclosure.

[0034] Figure 15 This illustration shows a schematic diagram of focused ultrasound irradiation under different treatment modes for blocking blood supply to target tissue and zonal irradiation in one embodiment of the present disclosure.

[0035] Figure 16 This illustration shows a schematic diagram of blocking blood supply to and preheating of the target tissue in one embodiment of the present disclosure.

[0036] Figure 17 Showing Figure 16 A schematic diagram of the target tissue after processing to illustrate tissue destruction.

[0037] Figure 18 This illustration shows a schematic diagram of cavitation bubbles generated under the target tissue blockade and tissue destruction mode in one embodiment of the present disclosure.

[0038] Figure 19 Showing Figure 18 A schematic diagram of thermal ablation performed on the target tissue after treatment.

[0039] Figure 20 A schematic diagram of the structure of a computer device according to an embodiment of the present disclosure is shown. Detailed Implementation

[0040] The following specific examples illustrate the implementation of this disclosure. Those skilled in the art can easily understand other advantages and effects of this disclosure from the information disclosed herein. This disclosure can also be implemented or applied through other different specific embodiments, and various details in this disclosure can be modified or changed according to different viewpoints and application modules without departing from the spirit of this disclosure. It should be noted that, unless otherwise specified, the embodiments and features in the embodiments of this disclosure can be combined with each other.

[0041] The embodiments of this disclosure will now be described in detail with reference to the accompanying drawings, so that those skilled in the art to which this disclosure pertains can readily implement it. This disclosure may be embodied in many different forms and is not limited to the embodiments described herein.

[0042] In this disclosure, references to terms such as "one embodiment," "some embodiments," "example," "specific example," or "some examples," etc., indicate that a specific feature, structure, material, or characteristic represented in connection with that embodiment or example is included in at least one embodiment or example of this disclosure. Furthermore, the specific features, structures, materials, or characteristics represented may be combined in any suitable manner in any one or a group of embodiments or examples. Moreover, without contradiction, those skilled in the art can combine and integrate the different embodiments or examples represented in this disclosure, as well as the features of those different embodiments or examples.

[0043] Furthermore, the terms "first" and "second" are used for illustrative purposes only and should not be construed as indicating or implying relative importance or implicitly specifying the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include at least one of that feature. In the representation of this disclosure, "a set" means two or more, unless otherwise explicitly specified.

[0044] For the purpose of clarity, devices unrelated to the description are omitted, and the same or similar components throughout the specification are given the same reference numerals.

[0045] Throughout this specification, when it is said that a device is "connected" to another device, this includes not only "direct connection" but also "indirect connection" by placing other components in between. Furthermore, when it is said that a device "comprises" a certain constituent element, unless otherwise stated otherwise, this does not exclude other constituent elements, but rather implies that other constituent elements may be included.

[0046] While the terms first, second, etc., are used in some examples herein to refer to various elements, these elements should not be limited by these terms. These terms are used only to distinguish one element from another. For example, first interface and second interface, etc., are used. Furthermore, as used herein, the singular forms “a,” “an,” and “the” are intended to also include the plural forms unless the context indicates otherwise. It should be further understood that the terms “comprising,” “including,” indicate the presence of the stated feature, step, operation, element, module, item, kind, and / or group, but do not exclude the presence, occurrence, or addition of one or more other features, steps, operations, elements, modules, items, kinds, and / or groups. The terms “or” and “and / or” as used herein are interpreted as inclusive, or mean any one or any combination thereof. Thus, “A, B, or C” or “A, B, and / or C” means “any one of: A; B; C; A and B; A and C; B and C; A, B, and C.” Exceptions to this definition will only occur if the combination of elements, functions, steps, or operations is inherently mutually exclusive in some way.

[0047] The technical terms used herein are for reference only to specific embodiments and are not intended to limit the scope of this disclosure. The singular form used herein includes the plural form unless the statement explicitly indicates otherwise. The word "comprising" as used in this specification means to specify a particular characteristic, region, integer, step, operation, element, and / or component, and does not exclude the presence or addition of other characteristics, regions, integers, steps, operations, elements, and / or components.

[0048] Although not explicitly defined, all terms, including technical and scientific terms used herein, shall have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure pertains. Terms defined in commonly used dictionaries shall be further interpreted as having a meaning consistent with the relevant technical literature and the message of the present disclosure, and shall not be over-interpreted as having an ideal or overly formulaic meaning unless otherwise defined.

[0049] Existing tumor thermal ablation techniques (such as radiofrequency, microwave, and laser) primarily induce tissue coagulation and necrosis through thermal effects. However, when treating larger tumors or tumors with indistinct borders, there are risks of insufficient ablation area, residual tissue at the edges, or thermal damage to surrounding healthy tissue. Cavitation techniques (such as high-intensity focused ultrasound cavitation and laser-induced cavitation) directly destroy cell structures through mechanical effects (shock waves, microjets), and are particularly adept at liquefying internal tissues. However, they are sensitive to tissue type and density, and using them alone may not ensure complete inactivation at the edges and may result in insufficient induction of immunogenic cell death. Currently, there is a lack of effective treatment regimens that integrate the two physical effects, leverage their respective advantages, and synergistically enhance the immune response.

[0050] Furthermore, current thermal ablation and tissue destruction techniques primarily focus on destroying the tumor as a whole, neglecting the treatment of its feeding vessels. This can lead to the retention of these vessels supplying the fibroid, allowing internal tissue to continue growing and potentially causing the fibroid to regenerate or enlarge, resulting in treatment failure or recurrence. Moreover, in cases like highly vascularized tumors, failure to address them can lead to significant bleeding during surgery, posing a substantial risk.

[0051] It is evident that the current treatment methods using focused ultrasound to ablate tumors have many shortcomings. Finding a more effective focused ultrasound approach for tumor treatment that overcomes these deficiencies has become a pressing technical challenge for the industry.

[0052] First, let me explain the definitions of some terms used in this disclosure.

[0053] Focused ultrasound (FUS) is a technique that focuses ultrasound waves onto a specific target area to achieve therapeutic functions (such as tumor ablation, neuromodulation, etc.) or imaging. FUS uses a high-intensity ultrasound beam to precisely focus on a specific target area (such as a tumor or lesion tissue) within the body, converting acoustic energy into heat energy or other biological effects to achieve therapeutic goals. This technology combines the advantages of image guidance, precise localization, and localized treatment. The advantages of FUS include: non-invasiveness, high precision, high repeatability, and minimal side effects. Major application areas include: tumor treatment, cosmetic and rehabilitation, neurological diseases, and other applications. For example, tumor treatment includes, but is not limited to, solid tumors such as uterine fibroids, liver cancer, breast cancer, prostate cancer, and pancreatic cancer. Cosmetic and rehabilitation applications include, but are not limited to: anti-aging and skin tightening (thermal effects cause collagen fibers to contract and initiate repair mechanisms, stimulating the synthesis of new collagen), fat ablation (mechanical effects destroy fat cell membranes), and non-invasive body sculpting. Other applications include, but are not limited to: essential tremor, osteoarthritis, and pain management.

[0054] Thermal effect of ultrasound: This refers to the phenomenon that when ultrasound propagates in a medium, some of its acoustic energy is converted into heat energy, causing the medium's temperature to rise.

[0055] The cavitation effect of ultrasound refers to the phenomenon where, when ultrasound propagates in a liquid, changes in local pressure create tiny bubbles. These bubbles grow and contract under the influence of ultrasound, eventually bursting and releasing enormous energy.

[0056] High-intensity focused ultrasound (HIFU) ablation refers to the conversion of the acoustic energy of focused ultrasound waves into thermal energy, generating high temperatures that cause the target tissue to coagulate and die.

[0057] Histotripsy refers to the use of focused ultrasound to rupture or homogenize target tissue through mechanical or cavitation effects.

[0058] Cavitational Histotripsy (CH): This technique uses microsecond-level pulsed ultrasound to create a high-density cloud of microbubbles at the focal point. As these bubbles expand and collapse, they release tremendous mechanical forces, breaking down tissue into subcellular fragments.

[0059] Boiling Histotripsy (BH): This technique uses millisecond-pulse ultrasound to destroy target tissue by generating boiling bubbles and their interaction with the tissue.

[0060] Hybrid Histotripsy (HH): Using sub-millisecond and / or millisecond pulsed ultrasound, a combination or fusion of CH and BH mechanisms is used to act on the target tissue, destroying or breaking it down to subcellular fragments.

[0061] Target tissue: refers to biological tissue containing blood vessels on the target object, such as benign tumors, malignant tumors or other lesions.

[0062] Target Animals: The target animals can be humans or other animals with vascular structures. Specifically, other animals can include companion animals, economic animals, ornamental animals, laboratory animals, and wild animals with vascular structures. For example, companion animals can include common animals such as dogs and cats, as well as "exotic pets," which refer to animals kept for companionship or enjoyment, excluding dogs and cats, encompassing birds, amphibians, reptiles, rodents, and fish, such as parrots, turtles, lizards, guinea pigs, and goldfish. Economic animals refer to animals kept for fur, meat, milk, draft, or other economic purposes, such as pigs, horses, cattle, sheep, deer, chickens, ducks, and geese. Ornamental animals can include, for example, animals displayed in zoos. Laboratory animals refer to animals kept for scientific applications, such as rabbits and mice. Wild animals refer to animals that grow in their natural environment and have not been domesticated, such as Pallas's cats and golden pheasants. Furthermore, while the above list primarily includes terrestrial animals, it may also include marine animals that can be classified into the above categories, such as dolphins, seals, sea lions, and whales.

[0063] Supply vessels: These refer to blood vessels within the target tissue that supply the tissue with nutrients. In some embodiments, the supply vessels may include vessels connecting within / outside the target tissue, including arteries, veins, capillaries, etc., or may include natural lumens within the body. In still other embodiments, the supply vessels may only include vessel types within the target tissue that are effective in blocking the supply of nutrients to the target tissue. The vessel type can be distinguished by its diameter. For humans, the range is less than 5 mm or 0.1–5 mm; for other animals, the range is less than 1 cm or 0.1–1 cm. By designing and replacing the hardware in a system for blocking supply vessels to target tissue, vessels of different diameter ranges can be blocked.

[0064] In view of the problems existing in the related technologies, the present disclosure provides a multi-mode focused ultrasound system based on the occlusion of the feeding vessel, which has the ability to carry out multiple modes in combination, including feeding vessel treatment, thermal effect mode and tissue destruction mode, effectively solving the problems in the related technologies.

[0065] As an example, the thermal effect mode may include a high-temperature thermal ablation mode, or other heating modes that achieve relatively low temperatures, for preheating of the target tissue. The focused ultrasound signal of the tissue destruction mode typically presents as a low-duty-cycle pulse signal. As an example, the tissue destruction mode may include a first tissue destruction mode and a second tissue destruction mode, wherein the pulse period of the focused ultrasound signal in the first tissue destruction mode may be longer than that in the second tissue destruction mode. In a further example, the first tissue destruction mode may be a boiling-type tissue destruction mode, and the second tissue destruction mode may be a cavitation cloud-type tissue destruction mode. Optionally, a third tissue destruction mode, such as a hybrid tissue destruction mode, may also be included.

[0066] like Figure 1 The diagram shows a schematic representation of a multi-mode focused ultrasound system based on vascular occlusion in one embodiment of this disclosure.

[0067] exist Figure 1 The multi-mode focused ultrasound system 100 includes a focused ultrasound unit 110, a detection imaging unit 120, and a control unit 130.

[0068] The focused ultrasound unit 110 includes a connected ultrasound treatment head 1110 and an ultrasound drive circuit 1120. The ultrasound drive circuit 1120 is used to provide an ultrasound drive signal to the ultrasound treatment head 1110 to excite ultrasound signal output. The focused ultrasound unit 110 may also include a power supply unit 140 connected to the ultrasound drive circuit 1120 for power supply.

[0069] In some embodiments, the ultrasonic treatment head 1110 includes a first ultrasonic transducer 1111 for emitting focused ultrasound. The first ultrasonic transducer 1111 is responsive to an ultrasonic drive signal to generate a focused ultrasound output to irradiate a focal point. In some embodiments, the first ultrasonic transducer 1111 includes a plurality of transducer elements. The transducer elements may be implemented as piezoelectric crystal elements (such as piezoelectric ceramics or composite materials) that convert electrical energy into ultrasonic energy generated by mechanical vibration. One or more of the transducer elements may form one or more array elements. In an alternative embodiment, the first ultrasonic transducer 1111 may be implemented as a self-focusing ultrasonic transducer, preferably a multi-channel phased array ultrasonic transducer. A self-focusing ultrasonic transducer includes one or more array elements. A multi-channel phased array transducer may include tens to hundreds of array elements, and the emission time of the ultrasonic waves from the plurality of array elements can be controlled by pulse signals with different delay times to change the phase relationship when the ultrasonic waves arrive at (or originate from) a point within an object, thereby achieving directional change and focusing of the ultrasonic waves. For example, by adjusting the emission delay (i.e., corresponding phase) of different array elements, the ultrasonic waves emitted by different array elements can all reach a peak or trough at a set position, thus creating a focal point at that position. Multi-channel phased-array ultrasonic transducers achieve focal point movement of focused ultrasound through electronic phase control, enabling better focus adjustment flexibility. Using phased-array ultrasonic transducers eliminates the need for mechanical structures to move the ultrasonic treatment head 1110 when the focused ultrasound focal point changes, effectively improving treatment efficiency, reducing damage to the target object, and increasing safety.

[0070] The ultrasonic drive circuit 1120 is coupled to the control unit 130 and the power supply unit 140, allowing the ultrasonic treatment head 1110 to be controlled to output focused ultrasound in various treatment modes. For example, in the thermal effect mode for achieving thermal ablation, the ultrasonic drive signal needs to have a relatively moderate voltage amplitude and a relatively high duty cycle. In the tissue destruction mode, the ultrasonic drive signal may be a pulse signal with a highly variable voltage amplitude and an extremely low duty cycle.

[0071] Optionally, the ultrasound driving circuit 1120 may include a signal generator 1121 and a power amplifier 1122. The signal generator 1121 is connected to the control unit 130 and the power amplifier 1122, and is controlled by the control unit 130 to output an ultrasound excitation signal with signal parameters matched to the selected treatment mode to the power amplifier 1122. The power amplifier 1122 is also connected to the power supply unit 140, and is used to amplify the ultrasound excitation signal based on the energy of the power supply signal output by the power supply unit 140 to generate an ultrasound driving signal. The power amplifier 1122 is also connected to the first ultrasound transducer 1111 to output the ultrasound driving signal. Thus, the power supply signal provides energy for amplifying the ultrasound excitation signal, which includes signal parameters of the generated focused ultrasound, including, for example, frequency and duty cycle. Ultrasound excitation signals with matching signal parameters can be output for different treatment modes. For example, the focused ultrasound signal in the thermal effect mode has a high duty cycle, such as ≥20% in the thermal effect mode for thermal ablation. For example, the duty cycle of focused ultrasound signals in tissue destruction modes is relatively low. For instance, the duty cycle ranges from 0.5% to 2% or 0.05% to 1%. For example, CH mode often uses microsecond-level (e.g., 0.5~20µs) pulsed ultrasound with a peak negative pressure >20 MPa and a duty cycle ≤1%; BH mode often uses millisecond-level pulsed ultrasound with a peak negative pressure of 10~20 MPa and a duty cycle ≤2%; HH mode often uses sub-millisecond and / or millisecond-level pulsed ultrasound with a peak negative pressure of 10~20 MPa.

[0072] In some embodiments, the signal parameters may be externally input to the control unit 130, such as from user input via a human-machine interface. The control unit 130 instructs the ultrasonic drive circuit 1120 to generate a corresponding ultrasonic excitation signal based on the signal parameters. In some embodiments, the ultrasonic drive circuit 1120 may include a signal generator 1121 for generating the ultrasonic excitation signal. The signal generator 1121 may be implemented using a processor (such as an MCU, DSP, etc.) combined with direct digital frequency synthesis (DDS) circuitry or other frequency generation circuitry.

[0073] As previously described, the power amplifier 1122 amplifies the ultrasonic excitation signal using the power supply signal output from the power supply unit 140, forming an ultrasonic drive signal that is output to the first ultrasonic transducer 1111 to excite ultrasonic output and focusing. Therefore, the intensity of the focused ultrasound output by the first ultrasonic transducer 1111 is determined by the amplitude of the power supply signal, while the duty cycle and frequency of the focused ultrasound signal are determined by the ultrasonic excitation signal. Since the system can generate dual-energy treatment modes, such as a thermal effect mode based on thermal effects and a tissue destruction mode based on cavitation / mechanical effects, and since the power amplifier 1122 needs to support extremely wide voltage and current ranges under different treatment modes, the power amplifier 1122 can be equipped with corresponding devices and / or structural features in terms of heat dissipation, voltage resistance, insulation, isolation, and detection.

[0074] In some embodiments, the power amplifier 1122 can be implemented based on a half-bridge or full-bridge amplifier circuit, or through, for example, an LC resonant amplifier circuit. In optional embodiments, the power amplifier 1122 can operate over a wide voltage range (e.g., 0~100V, or 10V~1000V, etc.), therefore its corresponding components should be selected to withstand higher voltages, such as capacitors, resistors, inductors, MOSFETs / SiC MOSFETs, gate drivers, diodes, etc., which can be selected to have a voltage rating at least one to several times higher than the highest operating voltage of the circuit. Especially in the tissue damage mode of cavitation / mechanical effects, the power amplifier 1122 will operate in a high-voltage pulse mode, with the number of pulses ranging from several to tens of thousands. Correspondingly, the high-voltage electronic components of the power amplifier 1122, especially diodes, gate drivers, or MOSFETs / SiC MOSFETs, have low propagation delays and fast switching speeds to ensure normal operation of the circuit at MHz frequencies.

[0075] Of course, the structure of the ultrasonic drive circuit 1120 is not limited to this, so the signal generator 1121 and the power amplifier 1122 are represented by dashed lines. In some embodiments, the signal generator 1121 and the power amplifier 1122 can be changed according to functional requirements. For example, the signal generator 1121 can be replaced by the control unit 130, in which case the ultrasonic drive circuit 1120 may include the power amplifier 1122 instead of the signal generator 1121.

[0076] The power supply unit 140 can be used to output power signals with electrical parameters suitable for each treatment mode. These electrical parameters include, but are not limited to, voltage, current, or power. In some embodiments, the power supply unit 140 can be used to output a first power signal suitable for a thermal effect mode (such as thermal ablation mode, or other heating modes), the first power signal having a high duty cycle. For example, the current value of the first power signal can reach several amperes to tens of amperes, and the voltage amplitude range is DC 0~100V, or 10V~60V. Correspondingly, optionally, the sound pressure level of focused ultrasound in the thermal effect mode of thermal ablation can be below 10MPa.

[0077] In some embodiments, the power supply unit 140 can be used to output a second power signal suitable for the tissue destruction mode, the second power signal having a pulsed current at a high voltage. Specifically, the voltage amplitude range of the second power signal can be DC 10V~1000V, or 15V~300V, etc. Correspondingly, optionally, the sound pressure range of the focused ultrasound implemented in the tissue destruction mode can be a wide range between negative and positive pressure, for example, the negative pressure peak is below -10~-20 MPa or below -20 MPa, and / or, the positive pressure peak is above 60 MPa.

[0078] The power supply unit 140 may include at least one power supply device with an adjustable output voltage, and the power supply unit 140 may be communicatively connected to the control unit 130 to control the output power signal. It is understood that achieving high voltage and high current with a single power supply device is difficult, and the power supply unit 140 would be larger and more expensive, which is detrimental to the miniaturization of the focused ultrasound system. Therefore, in some alternative embodiments, the power supply unit 140 may include multiple power supply devices.

[0079] In some embodiments, the power supply unit 140 may employ a programmable power supply or a programmable DC power supply with voltage regulation functionality. In other embodiments, it may also be implemented using a conventional switching power supply circuit or a customized power supply circuit combined with a voltage regulation circuit. Depending on the circuit implementation, the power supply unit 140 may be controlled by analog signals or digital signals. As an example, the voltage regulation circuit may be implemented as a DC voltage regulator circuit, which can achieve different intensity sound pressure outputs through voltage adjustment. In one example, the voltage regulation signal may be implemented as an analog signal, such as a continuously varying voltage or current signal, with different signal values ​​mapping different output voltages. In another embodiment, the voltage regulation signal may be implemented as a discrete level signal, such as PWM, I²C, SPI, GPIO, etc. Accordingly, the power supply unit 140 needs to provide an analog signal control interface and / or a digital signal control interface.

[0080] In some embodiments, the power supply unit 140 can be converted by a power conversion circuit to obtain a supply voltage suitable for the operating voltage range of the control unit 130, so as to supply power to the control unit 130. Alternatively, in other embodiments, the power supply unit 140 can be used only to supply power to the ultrasonic drive circuit 1120, and the control unit 130 can be independently powered by another power supply (and a power supply circuit capable of converting to a suitable supply voltage).

[0081] In some embodiments, the ultrasound treatment head 1110 can also be attached to a motion device 150, such as a multi-axis manipulator or a multi-axis mobile robot, to be manipulated for movement and to switch the focused ultrasound focal point. The motion device 150 may include a multi-degree-of-freedom motion controller with force feedback; a multi-degree-of-freedom collaborative robot or similar device can perform intraoperative motion detection or tracking. Optionally, dangerous events can be avoided by combining the identification of the target area boundary or safety boundary of the target tissue with force feedback from the motion device 150 to prevent collisions. The ultrasound treatment head 1110 mounted on a multi-degree-of-freedom collaborative robot enables convenient target area positioning, irradiation planning, and motion control during the treatment process. Movement can be controlled in various ways, such as visual guidance or a handle. The force feedback device at the end of the multi-degree-of-freedom collaborative robot enables stable circulation of the coupling medium (such as water) within the ultrasound treatment head 1110, ensuring good acoustic window and coupling during treatment. The motion device 150 can be connected to and controlled by the control unit 130 to switch the irradiation position of the focused ultrasound.

[0082] It should be noted that the orientation and focusing position of the ultrasonic treatment head 1110 shown in the illustrated embodiment are only schematic. In reality, the orientation angle of the ultrasonic treatment head 1110 can be changed in various ways by the motion device 150, or the focusing position can also be changed in various ways by the motion device 150 or electronic phase control. It is not limited to the schematic shown in the illustration.

[0083] The detection imaging unit 120 is used to detect target tissue to obtain target tissue data containing vascular information. In some embodiments, the detection imaging unit 120 may include one or more imaging devices based on medical imaging principles. For example, one or more of ultrasound imaging devices, computed tomography (CT) imaging devices, magnetic resonance imaging (MRI) imaging devices, positron emission tomography (PET) devices, and single-photon emission computed tomography (SPECT) devices. As an example, the detection imaging unit 120 can be implemented as a medical ultrasound imaging device, which comes in various types, the most common being B-mode ultrasound (i.e., black and white ultrasound) or D-mode ultrasound (i.e., Doppler diagnostic ultrasound, of which color Doppler is "color ultrasound"). It is understood that, based on the possible devices for implementing the detection imaging unit 120 exemplified above, the target tissue data can be obtained based on at least one detection image from ultrasound detection images, computed tomography (CT) detection images, magnetic resonance (MRI) detection images, single-photon emission computed tomography (SPECT) detection images, and positron emission tomography (PET) detection images.

[0084] Specifically, the principle by which the detection imaging unit 120 acquires vascular information is explained. In some examples, when using ultrasound as the detection medium for imaging, blood flow information can be obtained based on color / energy Doppler flow imaging (CDFI). Preferably, ultrasound contrast imaging technology can be used to effectively enhance the blood flow signal of tissues and organs by intravenously injecting an ultrasound contrast agent, better reflecting the blood perfusion situation. More preferably, superbmicrovascular imaging (SMI) technology can be used to accurately display low-speed and fine blood flow signals. By utilizing the interaction between ultrasound and human tissue, and through special imaging algorithms, the blood flow situation in microvessels can be displayed, allowing imaging of microvessels without the need for contrast agent injection. In other examples, target tissue data with vascular information can also be obtained through magnetic resonance imaging (MRI). In still other examples, target tissue data with vascular information can also be obtained through techniques such as computed tomography angiography (CTA). Specifically, a CT scan can be performed after intravenous injection of a contrast agent, and the data can be processed by computer to reconstruct a three-dimensional detection image of the blood vessels. In some other examples, target tissue data with vascular information can also be obtained by registration and fusion, such as through digital subtraction angiography (DSA) combined with target tissue data obtained from other probes of the target tissue.

[0085] In some embodiments, the detection imaging unit 120 can be connected to an imaging probe for detecting and imaging target tissue and a display, for detecting target tissue and imaging it on the display. The display is, for example, of the type LCD, LED, or OLED, for displaying the detected image.

[0086] It should be noted that, in addition to the aforementioned independent detection and imaging equipment, optionally, Figure 1 The detection imaging unit 120 in the example may also include a guide ultrasound probe 1112 integrated into the ultrasound treatment head 1110, the guide ultrasound probe 1112 including a second ultrasound transducer (not shown). The guide ultrasound probe 1112 moves with the ultrasound treatment head 1110, facilitating real-time detection of the focused ultrasound irradiation of the target tissue. That is, the detection imaging unit 120 may be a separate component or, in other embodiments, integrated into the same device, and its specific implementation is not limited.

[0087] In some embodiments, the target tissue data can be obtained by three-dimensional reconstruction of multiple detection images acquired from different angles of the target tissue. In specific implementation, the detection images of the target tissue at various angles can be obtained by moving the ultrasound probe (including but not limited to the guide ultrasound probe 1112) and / or adjusting other detection imaging devices (such as CT, MRI, etc.) to different detection angles, and then three-dimensional reconstruction of the target tissue can be performed based on each detection image to obtain the three-dimensional target tissue data.

[0088] In some embodiments, taking the detection of three-dimensional target tissue data by an ultrasound probe as an example, the ultrasound probe rotates around an axis corresponding to a cross-section of the target tissue, and acquires multiple detection images at intervals during the rotation. Then, three-dimensional reconstruction is performed based on the multiple detection images, and the spatial contour of the target tissue is extracted and combined with the vascular model to form three-dimensional target tissue data. In some embodiments, to facilitate the differentiation of blood vessel types and to more easily determine the supplying vessels during subsequent irradiation planning, the blood vessels in the vascular model can be distinguished by their thickness for differentiated display when displaying the vascular model. For example, blood vessels larger than 5 mm and those between 0.1 and 5 mm in the human body can be distinguished by markings of different colors, shapes, or patterns, or blood vessels between 0.1 and 1 cm and those larger than 1 cm in animals can be distinguished.

[0089] Optionally, a second ultrasonic transducer in the guiding ultrasonic probe 1112 may be coaxially arranged with the first ultrasonic transducer 1111. The second ultrasonic transducer is used to probe target tissue to provide a probe image to the detection imaging unit 120. In some embodiments, the detection imaging unit 120 may include an imaging circuit.

[0090] In specific application examples, the real-time detection images generated by the detection imaging unit 120 are used to locate the position and shape information of the target area before and during surgery, and to perform intraoperative monitoring. In some embodiments, target recognition technology based on detection image processing can be used to automatically detect and delineate the target area boundary or safety boundary (such as skin) in the detection image to ensure safe and effective treatment.

[0091] It is worth mentioning that the target tissue data containing vascular information can be composed of detection images acquired by a single detection imaging device (e.g., 3D reconstruction into a 3D model of the target tissue containing blood vessels). Alternatively, it can be based on separate 3D reconstructions of detection images acquired by different imaging devices. For example, the guided ultrasound probe 1112 facilitates the detection of target tissue data, but the detection of vascular information through a coupling medium may be inaccurate. Therefore, the guided ultrasound probe 1112 can be used to obtain a first 3D model of the target tissue without vascular information, while other detection imaging devices that can detect vascular information can obtain a second 3D model of the target tissue containing vascular information. However, since the detection position of the second model may be inferior to that of the guided ultrasound probe 1112, the accuracy of the second 3D model is slightly weaker than that of the first 3D model. Therefore, by registering and fusing the first and second 3D models of the target tissue, an accurate 3D model of the target tissue containing blood vessels can be obtained, thus forming the target tissue data.

[0092] In some embodiments, the detection imaging unit 120 may further include an imaging device or technology for detecting the stiffness of target tissue, such as an ultrasonic elastography device for shear wave elastography (SWE) and a magnetic resonance elastography device for magnetic resonance elastography (MRE).

[0093] Ultrasonic shear wave elastography utilizes the acoustic radiation force generated by an ultrasonic probe to excite shear waves, measuring their propagation velocity within the tissue and converting it into Young's modulus. It is simple to operate, highly real-time, and commonly used for superficial tissues (such as the breast and thyroid gland) or in situations requiring rapid assessment. Ultrasonic shear wave elastography yields results expressed as Young's modulus (reflecting a tissue's resistance to tension or compression).

[0094] Magnetic resonance elastography (MRI) calculates shear modulus by generating shear waves within the body and measuring their propagation velocity using MRI imaging techniques. It is suitable for imaging large areas of tissue, such as the liver and brain, and has significant advantages for imaging deep tissues. MRI detects shear modulus (which reflects a tissue's resistance to shear deformation).

[0095] In some embodiments, the therapeutic effects of treatment modalities such as thermal ablation modalities and tissue destruction modalities can be confirmed by analyzing the probe images of the target tissue through imaging techniques (such as contrast-enhanced US / MRI / CT to assess the extent of non-perfusion areas and the formation of liquefaction zones) and / or cavitation monitoring techniques (such as passive acoustic detection of cavitation noise and elastography to monitor changes in tissue stiffness).

[0096] Back Figure 1 The control unit 130, connected to the ultrasound drive circuit 1120 and the detection imaging unit 120, is used to determine an irradiation plan based on the target tissue data and execute the irradiation plan through the focused ultrasound unit 110, including: performing focused ultrasound irradiation on the blood supply vessels of the target tissue in a thermal effect mode to form thermal ablation, thereby blocking the blood supply to the target tissue; and, when the tissue destruction mode is adapted to the target tissue, irradiating the target tissue in a tissue destruction mode to form destruction.

[0097] It is worth noting that in the irradiation plan, the thermal effect mode for achieving thermal ablation and the tissue destruction mode of focused ultrasound irradiation can be performed sequentially in different orders. For example, the blood supply to the target tissue can be blocked first, followed by tissue destruction of the blocked target tissue. Alternatively, tissue destruction of the target tissue can be performed first (usually on the main central region 202), and then the blood supply vessels connected to the peripheral target tissue can be blocked. The selection and design of the treatment mode in the above irradiation plan can be determined according to the characteristics of the target tissue and the treatment needs, and its implementation method is not limited. It should also be noted that when the thermal effect mode for achieving thermal ablation is adapted to the target tissue, the entire target tissue can be ablated using the thermal effect mode without using the tissue destruction mode. The following illustrated embodiments will illustrate the possible implementation methods of the irradiation plan one by one.

[0098] In some embodiments, the control unit 130 may include an embedded controller containing an embedded processor such as a microcontroller unit 130 (MCU), a SoC, or an FPGA, which communicates with an external device (such as a host computer) to receive relevant instructions sent by the external device to control the operation of the circuit system. In other embodiments, the control unit 130 may also be implemented in an external device, for example, using a host computer as the control unit 130, communicating with the outside world and implementing control through a communication interface (such as a serial port like RS485 / 232). In some embodiments, the control unit 130 may include an embedded controller and a host computer with which it communicates. The embedded controller communicates with and controls the signal output of the power supply unit 140 and the ultrasonic drive circuit 1120, while the host computer communicates with and controls the detection imaging unit 120 and the motion device 150.

[0099] When irradiation is performed in the thermal effect mode, the control unit 130 sets the signal generator 1121 to output a first ultrasonic excitation signal with signal parameters adapted to the thermal effect mode (e.g., a higher duty cycle), and the power supply unit 140 to output a first power signal adapted to the thermal effect mode to the power amplifier 1122. The power amplifier 1122 amplifies the first ultrasonic excitation signal according to the first power signal to generate a first ultrasonic drive signal suitable for exciting the focused ultrasound output of the first ultrasonic transducer 1111 in the thermal effect mode. When irradiation is performed in the tissue destruction mode, the control unit 130 sets the signal generator 1121 to output a second ultrasonic excitation signal (e.g., a low duty cycle pulse signal) with signal parameters adapted to the tissue destruction mode, and the power amplifier 1122 amplifies the second ultrasonic excitation signal according to the second power signal to generate a second ultrasonic drive signal suitable for exciting the focused ultrasound output of the first ultrasonic transducer 1111 in the tissue destruction mode.

[0100] In some embodiments, the control unit 130 may be implemented as a single unit or as multiple separate control devices. As an example, the multiple control devices may include: a controller coupled to and integrated within the same focused ultrasound therapy device and the focused ultrasound unit 110 and the guiding ultrasound probe 1112; a controller in the motion device 150; and a host computer located outside the focused ultrasound therapy device and coupled to each of the controllers. The controller may be controlled by the host computer to issue commands to the controller to control the operation of the focused ultrasound unit 110 and the motion device 150.

[0101] In some embodiments, in addition to the selected treatment mode, the irradiation plan may also include a movement path of focused ultrasound irradiation of the target tissue, so that focused ultrasound irradiation is performed along the movement path in accordance with the determined treatment mode when the irradiation plan is executed.

[0102] Figures 2 to 17 The diagram shows a focused ultrasound irradiation performed by the ultrasound treatment head 1110 under one or more treatment modes.

[0103] Please refer to 2. Figure 3 and Figure 4 The diagram illustrates a method of irradiation in which focused ultrasound irradiation is used in multiple embodiments of this disclosure to thermally ablate the blood vessels 300 supplying the target tissue 200 through thermal effect mode, thereby forming a blockage.

[0104] exist Figure 2The image shows multiple externally connected blood vessels 300 to the target tissue 200. In this embodiment, the external blood supply to the target tissue 200 is blocked by irradiating the connection points A1, B1, and C1 between the target tissue 200 and the external blood vessels 300 using a thermal effect mode. The target tissue 200 itself can be ablated using a thermal effect mode, a tissue destruction mode, or a combination thereof, depending on its tissue characteristics. By blocking the connection with the external blood vessels 300, and then ablating the target tissue 200 through a tissue destruction / thermal effect mode, the treatment efficiency can be effectively improved compared to disconnecting the blood vessels 300 and waiting for the target tissue 200 to naturally die. This also avoids the risk of the blocked blood vessels re-establishing their supply through redirection.

[0105] exist Figure 3 The illustration demonstrates that, in addition to irradiating the connection point A2 between the target tissue 200 and the externally connected blood vessel 300 via a thermal effect mode, at least one external point D1 further away from the target tissue 200 is also irradiated to form a blocking point. This also achieves blood flow blocking between the external point and the connection point. In a possible implementation, the external point D1 can be irradiated before the connection point A2 to prevent blood from the blood vessel 300 from flowing to D1 when A2 is irradiated. Alternatively, in some other implementations, A2 can also be selectively irradiated first. In some applications, the target tissue 200 may be connected to an external tissue via the blood vessel 300; to prevent blood from the target tissue 200 from flowing to the external tissue (e.g., if the target tissue 200 is malignant), D1 can be blocked first. Optionally, this embodiment can be applied to scenarios where irradiation beyond the target tissue 200 is permissible, such as focused ultrasound irradiation therapy for liver, breast tumors, and soft tissue tumors.

[0106] exist Figure 4 The diagram illustrates how the supply vessels 300 within the target tissue 200 can also be irradiated using a thermal effect mode. Blood flow is blocked by thermal ablation of the supply vessels 300 within the target tissue 200 through irradiation. In this embodiment, the two supply vessels 300 within the target tissue 200 are irradiated at multiple points (or possibly single points) along their course to block blood flow in the supply vessels 300. Optionally, in the irradiation plan, irradiation focal points can be spaced out or densely arranged along the course of the vessels. The irradiation focal points can cover the entire vessel or only the key parts of the vessel.

[0107] In some scenarios, for highly vascularized target tissues 200, including but not limited to hemangiomas, cavernous hemangiomas, angioleiomyomas, nasopharyngeal angiofibromas, benign / malignant breast tumors, soft tissue tumors (such as angiosarcomas), liver cancer, renal cell carcinoma, adrenal tumors, thyroid cancer, uterine leiomyosarcoma, choriocarcinoma (seen in cases such as hydatidiform mole, miscarriage, or postpartum), and metastatic tumors (such as metastatic renal cell carcinoma, metastatic melanoma, and metastatic liver cancer), and for some tissues that may be poorly vascularized, oxygen deprivation can be achieved by blocking the main oxygen-supplying blood vessels. These tissues include, but are not limited to, pancreatic cancer and prostate cancer. Blocking the blood vessels within the target tissue 200 can prevent massive internal bleeding, and combining this with overall ablation of the target tissue 200 can also reduce the risk of metastasis.

[0108] It is particularly noteworthy that in traditional surgery, in order to reduce intraoperative bleeding, some highly vascularized tumors may require embolization of designated blood vessels using embolization materials. However, in this embodiment, by using focused ultrasound irradiation in thermal effect mode to the connection point of the supplying blood vessel 300 of the target tissue 200 and internal blood vessels, effective blood flow blockage can be achieved in medium and small blood vessels, achieving a hemostatic effect similar to "embolization". This method is much more convenient than the embolization method using embolization materials.

[0109] In addition, for cases of vascular blockage, such as vascular blockage caused by renal hypertension, vascular wall hypertrophy, or other thrombi, thrombolysis can be achieved through focused ultrasound irradiation (such as thermal ablation in thermal effect mode).

[0110] It should be noted that, Figure 2 , Figure 3 , Figure 4 The various methods of blocking blood vessels can be combined and implemented arbitrarily as needed, and are not limited to a single method.

[0111] Please see Figure 5 , Figure 6 and Figure 7 The image shows a specific application example of the multi-mode focused ultrasound system 100 in one embodiment of the present disclosure.

[0112] like Figure 5 The diagram shown illustrates the principle of one embodiment of this disclosure.

[0113] exist Figure 5 The diagram illustrates the various connection points between the target tissue 200 and the external blood supply vessel 300 during an irradiation program, in thermal effect mode, to block the external blood supply to the target tissue 200. Preferably, in Figure 5 The study also demonstrated the application of focused ultrasound in thermal effect mode to the outer points of two supplying blood vessels at a depth of 300 mm to achieve thermal ablation and blockage.

[0114] exist Figure 6 In the process, when the target tissue 200 is adapted to the tissue destruction mode, the target tissue 200 that has blocked blood supply is subjected to fragmented focused ultrasound irradiation in the tissue destruction mode.

[0115] Optionally, in Figure 6 The central region 202 of the target tissue 200 is irradiated by focused ultrasound in a tissue-damaging mode. Then in... Figure 7 Furthermore, focused ultrasound irradiation can be applied to the peripheral region 201 surrounding the central region 202 of the target tissue 200. An example of the irradiation mode used is the thermal effect mode. Of course, the mode can be changed according to the tissue characteristics, such as CH, BH, or HH in tissue destruction modes. Figure 7 Focused ultrasound irradiation "edge scanning" is used for Figure 6 The peripheral areas, where large-scale irradiation might be insufficient, have been reinforced to ensure the therapeutic effect of overall irradiation of the target tissue (200%).

[0116] It is worth mentioning that, in other embodiments, execution can also be performed first. Figure 6 The organization was damaged, and then the execution was carried out. Figure 5 The vascular blockage in the middle is not based on Figure 5 and Figure 6 The irradiation sequence is restricted.

[0117] It is also worth mentioning that, since the connection point of the external supply vessel 300 is located in the peripheral region 201 of the target tissue 200, and the internal vessel is located in the central region 202 of the target tissue 200, when the treatment mode of the peripheral region 201 is the same thermal effect mode as that of the connection point, both the peripheral region 201 and the connection point can be thermally ablated simultaneously. For example, as... Figure 8 and Figure 9 The diagram illustrates a specific application example of the multi-mode focused ultrasound system 100 in yet another embodiment of this disclosure. Figure 8 In this process, the central region 202 of the target tissue 200 can be irradiated first, such as with focused ultrasound irradiation in tissue destruction mode. Then, in Figure 9 In the middle, the outer area 201, including the connection point, is then subjected to focused ultrasound irradiation in thermal effect mode to complete thermal ablation, thereby effectively improving the execution efficiency of the irradiation plan.

[0118] It is understandable that, for example, if the intermediate region 202 needs to be subjected to focused ultrasound irradiation for thermal ablation, the intermediate region 202 of the target tissue 200 and the supplying blood vessel 300 of the intermediate region 202 can also be subjected to focused ultrasound irradiation in thermal effect mode for ablation.

[0119] Please refer to this again. Figure 10 and Figure 11This illustrates a specific application example of the multi-mode focused ultrasound system 100 in another embodiment of the present disclosure.

[0120] In this embodiment, different portions of the target tissue 200 may be located above and below an interface layer 500 of the target object. As an example, the interface layer 500 may be the epidermis, bone surface, or other layers of the target object, and the target tissue 200 may correspond to epidermal tumors (such as melanoma), bone tumors, or other types of tissue. Based on the above example of highly vascularized tumors, it can be seen that malignant tumors may have a rich blood supply.

[0121] exist Figure 10 The diagram illustrates that in an irradiation program, irradiation of the connection point between the subcutaneous target tissue 200 and the external supply vessel 300, as well as the internal supply vessel 300, via a thermal effect mode can achieve effective blood flow blocking and hemostasis. Furthermore, in... Figure 11 In China, regarding the economy Figure 10 The target tissue 200, whose supply blood vessel 300 is blocked, is subjected to focused ultrasound irradiation in a treatment mode adapted to its tissue characteristics, such as tissue ablation mode, to complete the ablation of target tissues 200 such as epidermal tumors and bone tumors.

[0122] Additionally, in some embodiments, if the target tissue 200 is a highly vascularized tissue, such as a highly vascularized tumor, a method such as... Figure 10 and Figure 11 The plan involves thermal ablation of the connection point and internal supply vessels 300, as well as irradiation of the target tissue 200 using tissue destruction (or complete thermal ablation). Further details will not be illustrated here.

[0123] Please refer to this again. Figure 12 and Figure 13 . Figure 12 This diagram illustrates focused ultrasound irradiation of a bifurcated feeding vessel 300 in one embodiment of the present disclosure. Figure 13 This diagram illustrates focused ultrasound irradiation of a bifurcated feeding vessel 300 in yet another embodiment of the present disclosure.

[0124] exist Figure 12 In the irradiation program, focused ultrasound irradiation can be performed on the bifurcation point of the supply vessel 300 in thermal effect mode to achieve thermal ablation. This disconnects the pathways between the upstream and downstream vessels at the bifurcation point.

[0125] However, in some embodiments, such as Figure 13As shown, following the blood flow direction (indicated by the arrows in the diagram), the feeding vessel 300 downstream of the bifurcation point 301 can be selected for focused ultrasound irradiation to achieve thermal ablation. For example, if only one branch vessel is the feeding vessel 300 of the target tissue 200, or if it connects to the downstream tissue while the upstream tissue is a malignant tumor, then only that branch vessel can be blocked to disconnect the blood supply or isolate the upstream tissue to prevent the metastasis of malignant cells.

[0126] In irradiation planning, when determining the treatment modality for 200 target tissue entities, the appropriate treatment modality can be determined based on tissue characteristic data, or it can be determined by combining tissue characteristic data with other accompanying imaging data.

[0127] In some embodiments, "tissue characteristics" is a multi-dimensional concept, referring to the characteristics of biological tissue in at least one aspect, such as structure, function, physical properties, and biochemical properties. Specifically, the basic types of animal tissues include: epithelial tissue, connective tissue, muscle tissue, and nervous tissue. Each tissue has its unique structural, functional, physical, biochemical, and physiological / pathological characteristics. From a physical / mechanical perspective, these may include at least one of the following: hardness, elasticity, toughness, ductility / extensibility, compressibility, density, and viscoelasticity. From a structural perspective, these may include at least one of the following: cell density, cell arrangement, fibrous composition, and matrix. From a functional perspective, these may include: protective functions (e.g., epidermis, bone tissue), supporting functions (e.g., bone tissue, cartilage), connection and support functions (e.g., various connective tissues), and locomotor functions (e.g., muscle tissue). From a biochemical perspective, these may include: water content, protein, lipids, mineral composition, etc. From a physiological / pathological perspective, this can include: metabolic activity, regenerative capacity, and changes in characteristics caused by disease (such as hardening, fibrosis, necrosis, softening, etc.).

[0128] On the other hand, organs are composed of one or more specific types of tissues combined according to certain structural and functional requirements. Therefore, the type, function, and overall characteristics of an organ largely depend on the type and characteristics of the tissues that constitute it. In optional embodiments, individual target tissue 200, or comprehensive information about target tissue 200 and its organs, can also be included in the "tissue characteristic data." For example, cysts, lipomas, myxomas, etc.; and hepatocellular carcinoma, breast cancer, early renal / prostatic hyperplasia, breast fibroadenoma, uterine fibroids, etc.

[0129] In some embodiments, the tissue characteristic data can be obtained by probing the target tissue 200 using a detection device. It is understood that, depending on the tissue characteristics, appropriate types of detection devices can be selected, such as ultrasound devices, CT devices, MRI devices, X-ray machines, and other imaging devices. Optionally, the detection device may include a second ultrasound transducer and a detection imaging unit 120, through which the second ultrasound transducer disposed within the ultrasound treatment head 1110 rapidly and efficiently images the target tissue 200 and analyzes it to obtain some of the tissue characteristics.

[0130] Therefore, the control unit 130 can intelligently determine the appropriate single treatment mode or multiple treatment modes to be implemented in combination based on the tissue characteristic data of the target tissue 200. This assists medical personnel in efficiently determining irradiation plans and improving treatment efficiency.

[0131] like Figure 14 The diagram shows a flowchart of a method for determining a treatment modality for a target tissue 200 based on tissue characteristics in one embodiment of this disclosure.

[0132] exist Figure 14 The method flow includes: Step S1401: Obtain tissue characteristic data of the target region in the target tissue 200, wherein the tissue characteristic data includes tissue stiffness.

[0133] In some embodiments, there are various methods for detecting the tissue stiffness of the target tissue 200, such as shear wave elastography (SWE) and magnetic resonance elastography (MRE).

[0134] In some embodiments, the control unit 130 can acquire depth information of the target tissue 200 and determine a matching detection imaging mode based on the depth information to detect and image the target tissue 200 to obtain the tissue characteristic data, thereby achieving automated selection and execution of the detection imaging mode. As an example, by setting depth conditions, such as a depth threshold / depth range, the detection imaging mode to be used can be determined by comparing the depth information of the target tissue 200 with these conditions.

[0135] Step S1402: Determine the appropriate treatment pattern in the pattern library based on the tissue characteristic data.

[0136] The pattern library establishes a relationship between organizational characteristic data and treatment patterns, allowing for the query of suitable treatment patterns based on the organizational characteristic data.

[0137] The relationship between tissue stiffness and treatment mode can be designed such that as tissue stiffness increases, the appropriate treatment mode changes from a tissue ablation mode to a thermal ablation mode, or from a thermal effect mode to a tissue ablation mode. Tissue stiffness can be related to the degree of fibrosis in the target tissue 200; the higher the degree of fibrosis, the higher the stiffness. A tissue ablation mode can be used when tissue stiffness is relatively low, while a thermal ablation mode is more likely to be used when tissue stiffness is high. Optionally, since the tissue ablation mode includes a first tissue ablation mode and a second tissue ablation mode, the selection between them can also be related to stiffness, progressing from a first tissue ablation mode with a lower duty cycle to a second tissue ablation mode with a relatively higher duty cycle (e.g., from CH to BH or HH) as stiffness increases, and finally to a thermal ablation mode.

[0138] The table below, using Young's modulus measured by SWE as a quantitative indicator, illustrates the ideal application range of Young's modulus in relation to CH, BH, HH, and thermal ablation: Table 1. Young's modulus and the ideal application range of CH, BH, and HH, as well as thermal ablation.

[0139] Furthermore, the table above provides examples of practical applications. For instance, the Young's modulus of liver tumors measured by SWE is approximately 10 kPa, thus making it suitable for CH, BH, and HH treatment modalities; or, the Young's modulus of uterine fibroids measured by SWE is 80-120 kPa or even higher, making it suitable for thermal ablation treatment.

[0140] It is understood that the tissue stiffness information mentioned above is only one dimension of tissue characteristic data. Other dimensions, such as blood supply information, can be added in other embodiments, and this is not a limitation. Therefore, the method of adapting treatment modes to the tissue characteristics of different diseased tissues disclosed in this invention, including the selection of CH, BH, HH, and thermal ablation, can effectively improve efficiency.

[0141] In some embodiments, the tissue characteristic data may further include blood supply information of the target tissue 200. This blood supply information can be presented in the detection image obtained by color Doppler ultrasound and can represent the richness of blood supply. Therefore, the correlation between "hardness + blood supply" and "treatment mode" can be added to the mode library. Table 2 below shows an optional example of the correlation between "hardness + blood supply" and "treatment mode".

[0142] In some embodiments, a machine learning-based classification model can be used to classify blood supply as "abundant" or "impoverished" based on input tissue-related blood flow imaging. As an example, the classification model can use blood flow imaging images (obtained via Doppler blood flow imaging, etc.) with preset labels of "abundant" or "impoverished" blood supply as training data to train the model. The loss is obtained by comparing the output with the labels, and the model parameters are adjusted based on the loss until the loss converges, completing the training. Thus, the trained classification model can be implemented according to the input blood flow. In some embodiments, the classification model can be implemented as one of the following types: such as Vector Machine (SVM), Random Forest (RF), fuzzy clustering, Ridge Regression, neural network, etc.; wherein, the neural network model can include CNN or related deep neural network models, such as AlexNet, VGG, ResNet, DenseNet, Inception, EfficientNet, etc.

[0143] Table 2. Relationship between "Hardness + Blood Supply" and "Treatment Mode"

[0144] In this table, tissue stiffness is the primary factor for determining the appropriate treatment mode, while blood supply information is a secondary factor. The richer the tissue blood supply, the greater the likelihood of it being suitable for tissue ablation. As the richness of tissue blood supply increases, the likelihood of the appropriate treatment mode being implemented as a tissue ablation mode is higher than that of it being implemented as a thermal ablation mode. Specifically, in the mode library, as the richness of tissue blood supply increases, the likelihood of it being implemented as a tissue ablation mode is higher than that of it being implemented as a thermal ablation mode.

[0145] In some embodiments, the control unit 130 may also determine the temporal / spatial information of the irradiation mode corresponding to the treatment mode in the treatment plan based on tissue characteristic data. For example, multiple treatment modes may be implemented in different regions of the target tissue 200, or may be implemented overlappingly in the same region.

[0146] In some embodiments, if it is determined, based on organizational characteristic data (or in conjunction with user input / selection / confirmation actions), that there is a need for the coordinated use of multiple treatment modes in a predetermined manner, then the coordinated execution of multiple treatment modes will be performed accordingly. The following provides examples of treatment plans that coordinate the use of multiple treatment modes.

[0147] In some embodiments, the synergistic requirement may include a zoned irradiation requirement. The zoned irradiation requirement refers to dividing the target tissue 200 into zones, with different treatment modalities applied to different zones; this is defined here as the "first synergistic mode".

[0148] In one example, if the target area (which may be a local or global area of ​​the target tissue 200) to be irradiated on the target tissue 200 may have globally uniform tissue characteristic data, such as a consistent degree of fibrosis, then only one treatment mode can be used.

[0149] However, in reality, due to the often irregular shape and complex internal structure of tumors (such as necrosis, cystic degeneration, hemorrhage, and calcification), as well as the differences in the acoustic properties of surrounding normal tissues (such as density, water content, and blood flow), the distribution of ultrasound energy within the target area may not be completely uniform. This can result in some areas receiving stronger treatment while others may receive insufficient treatment, leading to inconsistent degrees of fibrosis. Alternatively, tumors themselves may exhibit high heterogeneity, including differences in cell density, blood supply, and metabolic activity, all of which affect the absorption and transmission of ultrasound energy, thus impacting the uniformity of the treatment area. Furthermore, the microenvironment surrounding the tumor (such as vascular distribution, neural structures, and lymphatic drainage) can also affect the post-injury repair process, causing uneven distribution of fibrosis.

[0150] Accordingly, for different zones within the target area of ​​the target tissue 200 that may have different tissue characteristics, different treatment modalities can be applied to each zone. For example, zones with moderate fibrosis (which can be determined according to Table 1 above) can use BH or HH, zones with low fibrosis can use CH, and zones with high fibrosis can use HH or thermal ablation. In practical applications, for example, if the tumor volume is large, the central region has a high degree of fibrosis, and the peripheral region has a relatively low degree of fibrosis, then BH, HH, or thermal ablation are suitable for the central region, and CH / BH are suitable for the peripheral region.

[0151] The above examples illustrate the use of separate treatment modalities for regions with different tissue characteristics. In another example, a synergistic treatment modality could be adopted, selecting a superior treatment plan based on the tissue characteristic data of the target tissue 200. For instance, for a tumor with pathologically identified as malignant, its peripheral region exhibits outward invasive activity, while the interior contains malignant cells. Therefore, for the target tissue 200, which is identified as a "malignant tumor" based on tissue characteristic data, a corresponding synergistic multi-treatment modality can be provided. Specifically, in the generated treatment plan, a thermal ablation modal can be used on the outer region of the target tissue 200 to seal the edges and prevent spread, similar to "peeling an apple." Furthermore, for the treatment plan using a tissue destruction modal on the central region, the destroyed tissue serous fluid is also prevented from spreading by the sealed outer region after thermal ablation and coagulation, thus achieving a better treatment effect. This is defined here as the "second synergistic approach."

[0152] In other embodiments, a tissue ablation mode can be used on the edge region of the target tissue 200, while a thermal ablation mode is used on the central region, achieving another "apple-peeling" treatment method. The thermal ablation mode on the central region has high thermal deposition efficiency and is less likely to cause thermal damage to surrounding tissues. The tissue ablation mode offers high treatment precision, enabling accurate destruction of the edge region. As an example, the treatment method in this embodiment can be applied to, for example, target tissue 200 with a hard center and relatively soft edges.

[0153] like Figure 15 As shown, the ultrasound treatment head 1110 irradiates the connection point between the target tissue 200 and the external supply vessel 300, the internal supply vessel 300, and the peripheral region 201 in a thermal effect mode to induce thermal ablation, and irradiates the central region 202 of the target tissue 200 in a tissue destruction mode to destroy the tissue. As an example, the peripheral region 201 may completely surround the central region 202.

[0154] Specifically, thermal ablation blocks the supply of nutrients from the external blood vessels 300 to the target tissue 200, causing it to undergo natural necrosis and absorption. The synergistic treatment approach in this embodiment produces better efficiency and efficacy. By ablating and necrotizing the peripheral region 201 of the target tissue 200 and the supplying blood vessels 300, and internally destroying the tissue through lysis or homogenization, absorption is enhanced. Simultaneously, it does not increase the accumulation of heat, thus avoiding the risk of thermal damage to the near field or skin. Compared to full thermal ablation, it effectively reduces the total energy output, improves safety, and improves patient tolerance, reducing pain and treatment time.

[0155] In this embodiment, the connection point between the target tissue 200 and the external supply vessel 300, and the internal supply vessel 300 (or the external point, for example) are irradiated in thermal effect mode. Figure 3 Step D1 in the code can be set according to requirements. Figure 15 Before / after the intermediate thermal effect mode or tissue damage.

[0156] Further optionally, the first synergistic approach, which uses a treatment mode that is adapted to each partition with different tissue characteristics, can also be superimposed on the second synergistic approach in this embodiment. For example, if there are multiple partitions with different tissue characteristic data in the middle region 202, different first tissue destruction modes and second tissue destruction modes can be used, such as BH, CH, HH, etc.

[0157] Another way to enhance therapeutic effects through multimodal therapy is defined here as the "third synergistic approach." Please refer to [link to relevant documentation]. Figure 16 and Figure 17As shown. In the treatment plan of this embodiment, the ultrasound treatment head 1110 can first irradiate the target tissue 200 through a thermal effect mode to preheat it, i.e., as shown... Figure 16 As shown in the diagram. Furthermore, tissue destruction is achieved by irradiating the preheated target location (in this example, a focal point) using a tissue destruction mode, i.e., as... Figure 17 As shown in the illustration. In the synergistic approach of multiple treatment modes in this embodiment, the target tissue 200 is first heated to a certain extent by means of low-power continuous wave (parameters such as power 40W), which can be referred to as the preheating stage. Then, the tissue destruction mode is switched to enter the tissue destruction stage of high-power mechanical destruction or pulsed cavitation (parameters such as 1% duty cycle, power 400W). This tissue destruction stage utilizes the micron-sized cavitation nuclei generated by the collapse of boiling bubbles to expand the damage volume. That is, the tissue destruction effect of the tissue destruction mode is enhanced by the tissue preheating of the thermal effect mode. After several seconds or more, the cavitation bubbles collapse, restoring the sound wave penetration. The irradiation parameters used in the thermal effect mode in this embodiment may be different from the irradiation parameters of thermal ablation. In this embodiment, the thermal effect mode uses the thermal effect of focused ultrasound for preheating. The preheating effect is to reduce the liquid viscosity of the target tissue 200 and increase the density of cavitation nuclei, without necessarily reaching the degree of thermal ablation. Specifically, for example, the irradiation parameters used in the preheating stage are to gently and uniformly heat the target area, rather than rapidly thermally ablate. For example, using medium or low sound power / intensity and longer pulse duration. Additionally, the preheating phase for each execution can be heating a single focal point or heating multiple focal points within a defined area.

[0158] In this embodiment, the step of irradiating the connection point between the target tissue 200 and the external supply blood vessel 300, and the internal supply blood vessel 300 in thermal effect mode, can be set as needed. Figure 16 Before / after preheating in the intermediate heat effect mode, or Figure 17 Before / after the tissue destruction mode is executed. Preferably, it can be performed after preheating to enhance the thermal ablation effect.

[0159] The preheating and tissue destruction phases described above can be repeated alternately to improve energy deposition efficiency. In some embodiments, both phases can be repeatedly performed on each focal point of focused ultrasound, which can reduce treatment time while improving energy efficiency, achieving good preheating-enhanced tissue destruction efficacy.

[0160] In some alternative embodiments, the target temperature for preheating is 42°C to 50°C, or 45°C to 48°C; and / or, the duration of preheating is from 1 second to 5 minutes, or from 1 second to 30 seconds.

[0161] In some embodiments, the control unit 130 can accurately monitor the preheating temperature and start / stop irradiation or adjust irradiation parameters in a timely manner to avoid overheating or insufficient preheating. Optionally, in addition to directly measuring the temperature using a temperature sensor, it is more convenient to implement an indirect temperature estimation method. For example, the temperature can be estimated based on the signal parameters (such as intensity, amplitude, etc.) of the ultrasound scattering signal acquired from the focused ultrasound, or the temperature of the focal zone can be predicted based on parameters at the treatment site (such as ultrasound intensity or other parameters) using a temperature prediction model formed by simulation / training of experimental data.

[0162] In some embodiments, the interval between the thermal effect mode and the tissue destruction mode is limited to a preset duration; and / or, in the treatment plan, synergistic irradiation is performed sequentially on each focal point of the target tissue 200, the synergistic irradiation including the thermal effect mode and the tissue destruction mode being performed sequentially. Because excessively long intervals can lead to tissue cooling and weakened synergistic effects, the intervals are not allowed to be too long. For example, the tissue destruction phase may be initiated within 0-1 minutes or 1-5 minutes after the preheating phase ends.

[0163] In some embodiments, the target areas for preheating and tissue ablation may substantially overlap or completely overlap. Therefore, in the treatment plan, synergistic irradiation can be performed sequentially on each focal point of the target tissue 200, the synergistic irradiation including performing preheating and tissue ablation in the thermal effect mode followed by the tissue ablation mode. For example, focused ultrasound irradiation is performed on focal point A for preheating in the thermal effect mode and then switched to tissue ablation mode. The focus of focused ultrasound irradiation is then switched from focal point A to focal point B via electronic phase control or motion control, and the same process is performed on focal point B for preheating in the thermal effect mode and then switching to tissue ablation mode. This process is repeated to irradiate each focal point of the target tissue 200 defined in the treatment plan.

[0164] Therefore, all or almost all focal points within the target area of ​​the target tissue 200 can be directly switched to the tissue destruction mode focal point after the preheating of the thermal effect mode. The two treatment modes are switched on and off at the same focal point each time, requiring no movement during single-focal treatment; only the treatment mode changes. This helps reduce the number of focal point movements and improves the efficiency of treatment plan execution.

[0165] In some embodiments, the switching between thermal effect mode and tissue damage mode can be performed actively by the user, or preheating conditions such as the required preheating temperature and duration can be set in advance, and the switching can be automatically triggered when the preheating conditions are met.

[0166] The pretreatment effects of thermal ablation (lowering the cavitation threshold and viscosity) significantly improve the efficiency, controllability, and consistency of subsequent cavitation treatments (tissue ablation). Reduced acoustic pressure required for cavitation: Under the same cavitation effect, the peak negative pressure required after preheating is significantly reduced (e.g., by 20%-50%), improving safety (reducing the risk of damage to non-target areas) and equipment efficiency. Enhanced cavitation intensity and range: After preheating, at the same acoustic pressure, the generated cavitation bubbles are larger, collapse more violently, and the destruction range is wider and more uniform. Improved treatment consistency: Reduced impact of tissue heterogeneity (e.g., different fat / collagen contents) on cavitation effects, making treatment results more predictable and consistent across different tissue types or sites. Reduced treatment time: Because cavitation is more easily activated and enhanced, the cavitation irradiation time required to achieve the same destructive effect may be shorter. Reduced overall energy: Although a preheating step is added, the improved efficiency of the cavitation step may result in lower overall energy required to achieve the target effect or faster treatment completion. Expanding indications: This may make it feasible to treat tough tissues (such as certain fibrotic tissues) that were previously difficult to treat effectively due to their high cavitation threshold.

[0167] Another multi-modal synergistic approach to enhance treatment efficacy, defined here as the "fourth synergistic approach," can be found in [reference needed]. Figure 18 and Figure 19 In the treatment plan of this embodiment, the ultrasound treatment head 1110 can first irradiate the target tissue 200 through a tissue ablation mode to form a cavitation nucleus 400, i.e., as shown... Figure 18 As shown. The target tissue 200 is then irradiated using a thermal effect mode to induce thermal ablation based on the cavitation nuclei, i.e., as... Figure 19 As shown. Optionally, in this embodiment, the connection point between the target tissue 200 and the external supply vessel 300, and the internal supply vessel 300 (or the outer point of the external supply vessel) can also be irradiated in thermal effect mode. This vessel treatment step can be set as needed. Figure 18 Before / after the execution of the organization destruction mode, or Figure 19 Before and after irradiation in the intermediate thermal effect mode.

[0168] In this embodiment, the synergistic approach of the thermal effect mode and the tissue ablation mode is a dual-pulse relay mode. The tissue ablation mode in this embodiment can induce cavitation nuclei in the target tissue 200 using focused ultrasound with a short-duration, high-sound-pressure pilot pulse. The thermal effect mode in this embodiment can utilize focused ultrasound based on the main ablation pulse to enhance thermal deposition using the cavitation nuclei. Specifically, in the tissue ablation mode, the cavitation nuclei form a bubble cloud. These bubbles function similarly to microbubbles, enhancing the focal zone tissue thermal damage effect through both mechanical and thermal accumulation during subsequent thermal energy loading. This achieves a larger thermal ablation volume with the same time and energy, thus improving treatment efficiency.

[0169] It should be noted that the embodiments of the first to fourth synergistic modes described above are merely illustrative examples of some possible synergistic modes of thermal effect and tissue damage. In other embodiments, users can select other synergistic modes according to the tissue characteristics of the target tissue 200, and can define them themselves. Therefore, the embodiments listed above are not intended to limit the scope of the invention.

[0170] In some other embodiments, the target tissue 200 is ex vivo tissue, and the multi-mode focused ultrasound system 100 is also used to inactivate the target tissue 200.

[0171] like Figure 18 The diagram shown illustrates the structure of a computer device according to an embodiment of the present disclosure.

[0172] The computer device 2000 can be applied to the control unit 130 in the previous embodiment. The computer device 2000 includes a bus 2001, a processor 2002, and a memory 2003. The processor 2002 and the memory 2003 can communicate via the bus 2001. The memory 2003 can store program instructions. The processor 2002 implements at least some of the functions of the control unit 130 in the previous embodiment by executing the program instructions in the memory 2003.

[0173] Bus 2001 can be a Peripheral Component Interconnect (PCI) bus or an Extended Industry Standard Architecture (EISA) bus, etc. Buses can be categorized as address buses, data buses, control buses, etc. For ease of representation, although only one thick line is used in the diagram, this does not indicate that there is only one bus or one type of bus.

[0174] In some embodiments, the processor 2002 may be implemented as a central processing unit (CPU), a microprocessor unit (MCU), a system-on-chip (System-on-Chip), or a field-programmable array (FPGA). The memory 2003 may include volatile memory for temporary data storage during program execution, such as random access memory (RAM).

[0175] The memory 2003 may also include non-volatile memory for data storage, such as read-only memory (ROM), flash memory, hard disk drive (HDD), or solid-state disk (SSD).

[0176] In some embodiments, the computer device 2000 may further include a communicator 2004. The communicator 2004 is used for communication with external devices. In specific examples, the communicator 2004 may include one or more wired and / or wireless communication circuit modules. For example, the communicator 2004 may include one or more of, such as a wired network card, a USB module, a serial interface module, etc. The wireless communication protocols followed by the wireless communication module include, for example, Nearfield communication (NFC) technology, Infrared (IR) technology, Global System for Mobile Communications (GSM), General Packet Radio Service (GPRS), Code Division Multiple Access (CDMA), Wideband Code Division Multiple Access (WCDMA), Time-Division Code Division Multiple Access (TD-SCDMA), Long Term Evolution (LTE), Bluetooth (BT), Global Navigation Satellite System (GNSS), etc., one or more of these.

[0177] The above embodiments are merely illustrative of the principles and effects of this disclosure and are not intended to limit this disclosure. Any person skilled in the art can modify or alter the above embodiments without departing from the spirit and scope of this disclosure. Therefore, all equivalent modifications or alterations made by those skilled in the art without departing from the spirit and technical concept disclosed in this disclosure should still be covered by the protection scope of this disclosure.

Claims

1. A multi-mode focused ultrasound system based on vascular occlusion, characterized in that, include: A focused ultrasound unit includes a connected ultrasound treatment head and an ultrasound drive circuit; the ultrasound drive circuit allows controlled driving of the ultrasound treatment head to output focused ultrasound in multiple treatment modes; the multiple treatment modes include a thermal effect mode and a tissue destruction mode; The detection imaging unit is used to detect target tissue to obtain target tissue data containing vascular information; The control unit, connected to the ultrasound drive circuit and the detection imaging unit, is used to determine the irradiation plan based on the target tissue data and execute the irradiation plan through the focused ultrasound unit, including: performing focused ultrasound irradiation on the blood supply vessels of the target tissue in thermal effect mode to form thermal ablation, thereby blocking the blood supply of the target tissue; Furthermore, when the tissue destruction mode is adapted to the target tissue, the target tissue is irradiated in the tissue destruction mode to form destruction.

2. The multi-mode focused ultrasound system according to claim 1, characterized in that, The method of performing focused ultrasound irradiation on the blood vessels supplying the target tissue in thermal effect mode to achieve thermal ablation includes at least one of the following: Irradiate the target tissue at various connection points with external blood vessels inside / outside and on the surface of the target tissue to block the external blood supply to the target tissue; Irradiate the blood vessels supplying the target tissue to block blood flow; Irradiate at least one external point on the external supply vessel that is further away from the target tissue from the junction point with the target tissue to form a blocking point.

3. The multi-mode focused ultrasound system according to claim 1, characterized in that, The irradiation program includes: In thermal effect mode, the target tissue is irradiated at each connection point with the external blood supply vessel to block the external blood supply to the target tissue; and, when the target tissue is adapted to tissue destruction mode, the target tissue before / after blocking blood supply is subjected to fragmented focused ultrasound irradiation in tissue destruction mode.

4. The multi-mode focused ultrasound system according to claim 3, characterized in that, The organization's irradiation program also includes: The peripheral region of the target tissue is irradiated with focused ultrasound in either thermal effect mode or tissue destruction mode; wherein, if irradiated with focused ultrasound in thermal effect mode, the peripheral region and each of the connection points are irradiated with focused ultrasound together.

5. The multi-mode focused ultrasound system according to claim 3, characterized in that, Prior to the various connection points between the irradiated target tissue and the external supply vessels in the thermal effect mode, the irradiation plan further includes: In thermal effect mode, at least one external point on the external supply vessel that is farther away from the target tissue from the connection point with the target tissue is irradiated with focused ultrasound to form a blocking point.

6. The multi-mode focused ultrasound system according to claim 1, characterized in that, The target tissue is a blood-rich tissue; the irradiation plan includes: focusing ultrasound irradiation of the blood-supplying vessels in the blood-rich tissue in a thermal effect mode to form thermal ablation.

7. The multi-mode focused ultrasound system according to claim 1, characterized in that, The control unit is also configured to continue performing at least one round of focused irradiation in thermal effect mode and / or tissue destruction mode in response to the presence of stubborn / residual parts in the irradiated target tissue.

8. The multi-mode focused ultrasound system according to claim 1, characterized in that, The irradiation program includes: In thermal effect mode, focused ultrasound irradiation is applied to the bifurcation point of the feeding vessel to achieve thermal ablation; or, In thermal effect mode, feeding vessels are selected from multiple downstream branch vessels based on a bifurcation point and focused ultrasound irradiation is performed to form thermal ablation.

9. The multi-mode focused ultrasound system according to claim 1 or 3, characterized in that, The determination of the irradiation plan based on the target tissue data further includes: Acquire tissue characteristic data of the target tissue, wherein the tissue characteristic data includes at least tissue stiffness; Based on the tissue characteristic data, a suitable treatment modality is determined in the modality library to develop an irradiation plan; The appropriate treatment mode changes from tissue damage mode to thermal effect mode, or from thermal effect mode to tissue damage mode, depending on changes in tissue characteristic data or tissue characteristic data and other imaging data used in conjunction.

10. The multi-mode focused ultrasound system according to claim 9, characterized in that, The step of determining the irradiation plan based on the target tissue data includes: The zonal irradiation requirements are determined based on the size and / or type of the target tissue. In response to the requirements of zonal irradiation, the peripheral and intermediate regions of the target tissue are determined; It is determined whether to apply one of the tissue destruction mode and the thermal effect mode that achieves thermal ablation to the outer region and the middle region, respectively.

11. The multi-mode focused ultrasound system according to claim 9, characterized in that, The step of determining the irradiation plan based on the tissue characteristic data further includes: The enhanced irradiation requirement is determined based on the tissue characteristic data; In response to the need for enhanced irradiation, one of the thermal effect mode and the tissue destruction mode is applied to the target tissue sequentially, thereby enhancing the tissue destruction and / or thermal ablation effect.

Citation Information

Patent Citations

  • Multi-frequency harmonic superposition two-stage millisecond long ultrasonic pulse histotripsy control method and system

    CN113340689A

  • System for feeding vessel occlusion of target tissue

    CN118267053A

  • Novel ultrasonic focusing thermal therapy device and application

    CN119185818A

  • Multi-mode focused ultrasound treatment system and method for setting pulse emission parameters

    CN120617856A

  • Focused ultrasound system with multiple treatment modes

    CN120919551A